Awadzi K, Attah S K, Addy E T, Opoku N O, Quartey B T, Lazdins-Helds J K, Ahmed K, Boatin B A, Boakye D A, Edwards G
Onchocerciasis Chemotherapy Research Centre (OCRC), Hohoe Hospital, P.O. Box 144, Hohoe, Ghana.
Ann Trop Med Parasitol. 2004 Jun;98(4):359-70. doi: 10.1179/000349804225003442.
The pathogenesis of the sub-optimal response of Onchocerca volvulus to ivermectin was investigated in a 30-month follow-up of 28 individuals who, in a previous study, had been found to show a sub-optimal (N = 15) or adequate response (N = 13) to multiple treatments with the drug. Verbal informed consent was obtained before each subject was given a general clinical and ocular examination. Skin snips were taken from both iliac crests and both calves. Seventeen nodule carriers were hospitalized for nodulectomy. Adult worms were harvested, embryogrammes were constructed and all developmental stages were counted; degenerate, stretched microfilariae were noted separately. All the subjects were in good general health and all except one had received at least one additional treatment with ivermectin since the earlier study. A large proportion of the adult female worms in 10 out of the 11 sub-optimal responders who were nodule carriers were in full embryonic production but most of the stretched microfilariae they carried were degenerate. This picture is similar to that found in adult worms exposed to the first dose of ivermectin. In one subject who had no viable worms in his nodules, the existence of occult but actively reproductive worms was inferred from the high level of microfilaridermia observed less than 12 months after treatment. These observations confirm the existence of populations of adult female O. volvulus that respond poorly to repeated doses of ivermectin. The use of suramin in the treatment of the sub-optimal responders is discussed.
在一项对28名个体进行的为期30个月的随访研究中,调查了盘尾丝虫对伊维菌素反应欠佳的发病机制。在之前的一项研究中,发现这些个体对该药物的多次治疗表现出欠佳反应(N = 15)或充分反应(N = 13)。在对每个受试者进行全面临床和眼部检查之前,均获得了口头知情同意。从双侧髂嵴和双侧小腿采集皮肤切片。17名结节携带者因结节切除术住院。收集成虫,构建胚胎图并对所有发育阶段进行计数;分别记录退化、拉长的微丝蚴。所有受试者总体健康状况良好,自早期研究以来,除一人外,所有人均至少接受过一次伊维菌素的额外治疗。在11名表现欠佳的结节携带者应答者中,有10人的大部分成年雌虫处于完全胚胎生成状态,但它们携带的大多数拉长微丝蚴已退化。这一情况与首次接触伊维菌素的成虫中发现的情况相似。在一名结节中没有活虫的受试者中,根据治疗后不到12个月观察到的高微丝蚴血症水平,推断存在隐匿但仍在活跃繁殖的虫体。这些观察结果证实了存在对重复剂量伊维菌素反应欠佳的成年雌性盘尾丝虫群体。文中还讨论了使用苏拉明治疗反应欠佳者的情况。